Astex Pharmaceuticals to Present at AACR-NCI-EORTC
October 14 2013 - 3:30PM
Astex Pharmaceuticals, Inc., a pharmaceutical company dedicated to
the discovery and development of novel small molecule therapeutics,
today announced four presentations of developmental and
collaboration programs will be made at the AACR-NCI-EORTC
International Conference on Molecular Targets and Cancer
Therapeutics, Oct. 20 and 21, in Boston.
SGI-110 |
Abstract # A256 |
|
Poster Presentation |
Sunday, Oct. 20 |
12:30 - 7:30 p.m. EDT |
Improved Antitumor Activity by
Sequencing SGI-110 with CTLA-4 Blockade in a Syngenic Mouse
Model |
|
|
|
XIAP |
Abstract #A55 |
|
Poster Presentation |
Sunday, Oct. 20 |
12:30 - 7:30 p.m. EDT |
Potent, dual cIAP1/XIAP
antagonists induce apoptosis in a melanoma stem cell
population |
|
|
|
LEE011 |
Abstract #PR02 |
|
Proffered Paper Session |
Sunday, Oct. 20 |
5:45 – 6 p.m. EDT |
|
|
|
|
Abstract #B264 |
|
Novartis Poster Presentation |
Monday, Oct. 21 |
12:30 – 3 p.m. & 6:30 – 7:30 p.m.
EDT |
LEE011- An orally bioavailable,
selective small molecule inhibitor of CDK4/6: Reactivating Rb in
cancer |
|
|
|
LEE011 |
Abstract #A276 |
|
Novartis Poster Presentation |
Sunday, Oct. 20 |
12:30 - 3 p.m. & 6:30 – 7:30 p.m.
EDT |
Phase 1 multicenter, open label,
dose-escalation study of LEE011, an oral inhibitor of
cyclin-dependent kinase 4/6, in patients with advanced solid tumors
or lymphomas |
Select posters will be made available for viewing on the Astex
website http://astx.com/pipeline/publications/.
About Astex Pharmaceuticals
Astex Pharmaceuticals is dedicated to the discovery and
development of novel small molecule therapeutics with a focus on
oncology. Astex is developing a proprietary pipeline of novel
therapies and is creating de-risked products for collaborations
with leading pharmaceutical companies. Astex Pharmaceuticals
developed DACOGEN® (decitabine) for Injection and receives
significant royalties on global sales.
For more information about Astex Pharmaceuticals, Inc., please
visit http://www.astx.com.
CONTACT: Timothy L. Enns
Astex Pharmaceuticals, Inc.
Senior Vice President
Corporate Communications & Marketing
Tel: +1 (925) 560-2810
E-mail: tim.enns@astx.com
Susanna Chau
Astex Pharmaceuticals, Inc.
Manager
Tel: +1 (925) 560-2845
E-mail: susanna.chau@astx.com
Astex Pharmaceuticals, Inc. (MM) (NASDAQ:ASTX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Astex Pharmaceuticals, Inc. (MM) (NASDAQ:ASTX)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Astex Pharmaceuticals, Inc. (MM) (NASDAQ): 0 recent articles
More News Articles